These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22739696)

  • 1. Impact of gp120 on dendritic cell-derived chemokines: relevance for the efficacy of gp120-based vaccines for HIV-1.
    Vani J; Sharma M; Shaila MS; Kaveri SV; Bayry J
    Clin Vaccine Immunol; 2012 Aug; 19(8):1335-6. PubMed ID: 22739696
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV gp120 vaccine (Chiron).
    Drugs R D; 1999 Jun; 1(6):445-7. PubMed ID: 10566078
    [No Abstract]   [Full Text] [Related]  

  • 3. Update on HIV vaccines: which way now?
    Stevceva L
    Curr Med Chem; 2011; 18(26):3952. PubMed ID: 21824097
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV vaccine AIDSVAX.
    Drugs R D; 1999 Jun; 1(6):456-8. PubMed ID: 10566083
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV vaccine vCP205. ALVAC-HIV vCP205, ALVAC vCP205.
    Drugs R D; 1999 Jun; 1(6):459-60. PubMed ID: 10566084
    [No Abstract]   [Full Text] [Related]  

  • 6. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
    Bower JF; Green TD; Ross TM
    Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine to prevent AIDS overstated.
    Lewis D
    Res Initiat Treat Action; 1999 Jan; 5(1):11-2. PubMed ID: 11366223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RV144 Thai HIV vaccine trial.
    Plotkin SA
    Hum Vaccin; 2010 Feb; 6(2):159. PubMed ID: 20431337
    [No Abstract]   [Full Text] [Related]  

  • 9. Prime-boost immunization strategies against HIV.
    Barnett SW; Klinger JM; Doe B; Walker CM; Hansen L; Duliège AM; Sinangil FM
    AIDS Res Hum Retroviruses; 1998 Oct; 14 Suppl 3():S299-309. PubMed ID: 9814958
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic mechanism for human immunodeficiency virus type 1 gp120 vaccine failure.
    O'Toole C; Müller S; Nara P; Köhler H
    J Infect Dis; 1996 Feb; 173(2):512-3. PubMed ID: 8568327
    [No Abstract]   [Full Text] [Related]  

  • 11. HIV vaccines. Viral envelope fails to deliver?
    Bolognesi DP; Matthews TJ
    Nature; 1998 Feb; 391(6668):638-9. PubMed ID: 9490406
    [No Abstract]   [Full Text] [Related]  

  • 12. In search of a human immunodeficiency virus vaccine.
    Bartholomew CF
    West Indian Med J; 2000 Sep; 49(3):187-9. PubMed ID: 11076204
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibodies to HIV-1: aiming at the right target.
    Eggink D; Melchers M; Sanders RW
    Trends Microbiol; 2007 Jul; 15(7):291-4. PubMed ID: 17566740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C.
    Gómez CE; Perdiguero B; Jiménez V; Filali-Mouhim A; Ghneim K; Haddad EK; Quakkelaar ED; Delaloye J; Harari A; Roger T; Duhen T; Sékaly RP; Melief CJ; Calandra T; Sallusto F; Lanzavecchia A; Wagner R; Pantaleo G; Esteban M
    PLoS One; 2012; 7(4):e35485. PubMed ID: 22536391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An alternative and effective HIV vaccination approach based on inhibition of antigen presentation attenuators in dendritic cells.
    Song XT; Evel-Kabler K; Rollins L; Aldrich M; Gao F; Huang XF; Chen SY
    PLoS Med; 2006 Jan; 3(1):e11. PubMed ID: 16381597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4-induced epitopes in the HIV envelope glycoprotein, gp120.
    DeVico AL
    Curr HIV Res; 2007 Nov; 5(6):561-71. PubMed ID: 18045112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Public health. A sound rationale needed for phase III HIV-1 vaccine trials.
    Burton DR; Desrosiers RC; Doms RW; Feinberg MB; Gallo RC; Hahn B; Hoxie JA; Hunter E; Korber B; Landay A; Lederman MM; Lieberman J; McCune JM; Moore JP; Nathanson N; Picker L; Richman D; Rinaldo C; Stevenson M; Watkins DI; Wolinsky SM; Zack JA
    Science; 2004 Jan; 303(5656):316. PubMed ID: 14726576
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of dendritic cell-mediated immune responses against HIV-1 by antigen-capturing nanospheres in mice.
    Kawamura M; Wang X; Uto T; Sato K; Ueno M; Akagi T; Hiraishi K; Matsuyama T; Akashi M; Baba M
    J Med Virol; 2005 May; 76(1):7-15. PubMed ID: 15778965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1MN recombinant gp120 vaccine serum, which fails to neutralize primary isolates of HIV-1, does not antagonize neutralization by antibodies from infected individuals.
    Wrin T; Nunberg JH
    AIDS; 1994 Nov; 8(11):1622-3. PubMed ID: 7848602
    [No Abstract]   [Full Text] [Related]  

  • 20. RV144: old vs. new.
    Weiner DB
    Hum Vaccin; 2010 Feb; 6(2):159-61. PubMed ID: 20431335
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.